Boca Scientific Inc

09/04/2026

In a new study, researchers uncovered around 1,200 variants associated with personality traits. Common genetic variants account for a small percentage of variation in the ‘Big Five’ personality traits, connecting to health & lifestyle factors.

Researchers identify more than 1,200 personality-linked genetic variants, with effects largely independent of family background.

09/03/2026

Researchers at Mass General Brigham leveraged our SilenceMag to macrophages with RSK1-targeting , enabling RSK1 knockdown to investigate the role of RSK1 in activation.
See it on our website here: https://bocascientific.com/products/sm00000-66-detail
https://www.science.org/doi/10.1126/sciadv.ady4193

Proinflammatory activation of macrophages promotes various inflammatory disorders. The molecular mechanisms underlying macrophage activation, particularly in the context of nuclear translocation of proinflammatory response mediators, remain obscure. We ...

09/01/2026

A team at Lund University found how heme can trigger a chain reaction in the blood that activates inflammation, making blood vessels more permeable. Their findings could have implications for conditions involving the breakdown of red blood .

Heme is released from red blood cells during hemolytic uremic syndrome (HUS). Here, we investigated hemolysis-induced kallikrein-kinin system activation and the interaction between heme and clotting factor XII (FXII).

08/28/2026

Researchers Indiana University School of Medicine & University of Colorado Anschutz identified the process that may explain why colorectal can cause severe muscle and bone loss. Cancer can send a signal to the liver, producing IGFBP1, causing the loss of muscle & bone.

Colorectal cancer often causes cachexia, a wasting syndrome that weakens muscles and bones. Here, the authors show that a tumor-liver signaling relay driven by FGF21 and IGFBP1 promotes this decline, identifying a potential target to preserve musculoskeletal health.

08/26/2026

Paleontologists found some insects from hundreds of millions of years ago had many more legs than six. This significant finding, suggests many-legged critters represent missing links between modern winged insects & their predecessors.

Previously collected fossils prove a treasure trove for understanding the origin of insects

08/25/2026

Researchers leveraged our Antibody Stabilizer to stabilize antibody-metal conjugates for CyTOF analysis of virus-specific CD8⁺ T cells. CyTOF measured multiple markers at once to profile T-cell phenotype & function.
See it: https://bocascientific.com/106-131-52-detail
https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(26)00363-0

Ma et al. perform deep-phenotyping of CD8+ T cells specific for viruses implicated in LC pathogenesis: SARS-CoV-2, CMV, and EBV. These T cells from LC individuals share features of terminal differentiation, activation, exhaustion, and cytolysis. The inability to dampen acute-phase cytolytic viral-sp...

08/24/2026

A team at UC Riverside identified multiple targets for that could help treat Crimean-Congo hemorrhagic fever (CCHFV). They focused on the nucleocapsid , and discovered it can offer protection no matter where the antibodies attach.

This study identifies four antigenic sites on CCHFV NP, showing that protection is independent of head or stalk location. It maps the highly conserved binding epitope of mAb-9D5 in the head domain, enabling broad-spectrum efficacy and opening the door for effective combination therapies.

08/21/2026

Our Environmental Stress Antibodies from Agrisera are ideal for involved in stress response. Receive 15% off Environmental Stress Antibodies now through September, 2026!
See them: https://bocascientific.com/brands/agrisera

08/20/2026

Researchers have grown brain that mirror the development of the human brain for more than five years. These are the longest-lived made in a laboratory, watching them develop could help scientists understand how diseases affect the brain.

Models of how the brain changes over time could help researchers to understand how diseases affect the organ later in life.

08/14/2026

A new mRNA-based vaccine from Moderna, Inc. is anticipated to be available for the 2026-27 flu season. The new platform allows it to be rapidly reformulated to match circulating strains. This could solve the issue of slow manufacturing!

Moderna’s newly approved vaccine could allow manufacturers to respond more rapidly to changing influenza strains.